The Use of HEMOBAG to Salvage Blood After Cardiac Surgery
Status:
Terminated
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The avoidance of blood transfusions benefits the patient. Cardiopulmonary bypass (CPB) is
routinely used in complex cardiac surgeries. This device requires circulating blood through
an oxygenator and pump while the heart is stopped. Upon discontinuation of CPB, the volume of
blood in the CPB circuit, approximately 1 to 1.5 liters, is currently processed for the red
cell components of the blood. Yet, all the other blood components are available in this
volume of blood, but are discarded. The Hemobag filters allow for whole blood reinfusion
rather than just red cell reinfusion. Thus, the patient's own platelets, for example, are
returned to the patient. The product is just being used clinically and we, the investigators
at University of Medicine and Dentistry, New Jersey, have been asked to perform a study on
our normal practice (red blood cell return as described above) compared to the whole blood
return available with the Hemobag™.
Phase:
Phase 2
Details
Lead Sponsor:
University of Medicine and Dentistry of New Jersey